| Print
Coherus Oncology Inc (CHRS)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.
Address
333 Twin Dolphin Drive
Suite 600
Redwood City
CA
USA
94065
Telephone
+1 800 7945434
Forecast key dates
| Name | Key Date |
|---|---|
| Coherus Oncology Inc Fourth Quarter Earnings Conference Call for 2026 | 2027-03-09T16:30:00 |
| Coherus Oncology Inc Fourth Quarter Earnings Results for 2026 | 2027-03-09T00:00:00 |
| Coherus Oncology Inc Annual Report for 2026 | 2027-03-09T00:00:00 |
| Coherus Oncology Inc Third Quarter Earnings Conference Call for 2026 | 2026-11-06T17:00:00 |
| Coherus Oncology Inc Third Quarter Earnings Results for 2026 | 2026-11-06T00:00:00 |
| Coherus Oncology Inc Second Quarter Earnings Conference Call for 2026 | 2026-08-07T17:00:00 |
| Coherus Oncology Inc Second Quarter Earnings Results for 2026 | 2026-08-07T00:00:00 |
| Coherus BioSciences Inc Annual General Meeting for 2026 | 2026-06-11T13:30:00 |
| Coherus BioSciences Inc First Quarter Earnings Conference Call for 2026 | 2026-05-12T17:00:00 |
| Coherus BioSciences Inc First Quarter Earnings Results for 2026 | 2026-05-12T00:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.